Microbiological and molecular detection of VIM-1 metallo beta lactamase-producing Acinetobacter baumannii

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 7, 2014, Pages 965-970

  El Ageery, S M ^a,b   Al Hazmi, S S ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Acinetobacter baumannii; E test; PCR; VIM 1 metallo beta lacta mase

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; METALLO BETA LACTAMASE; NEOMYCIN; PIPERACILLIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAMASE; CARBAPENEM DERIVATIVE; VIM-1 METALLO-BETA-LACTAMASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; DISK DIFFUSION; EPSILOMETER TEST; HUMAN; MICROBIOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; VIM 1 GENE; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; CHILD; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; MULTIDRUG RESISTANCE; OUTPATIENT DEPARTMENT; SAUDI ARABIA; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CHILD; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SAUDI ARABIA; YOUNG ADULT;

EID: 84902188895     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. PELEG AY, SEIFERT H, PATERSON DL Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-582.
2. GUSTEN WM, HANSEN EA, CUNHA BA A baumannii pseudo meningitis. Heart Lung 2002; 31: 76-78.
3. PEYMANI A, NAHAEI MR, FARAJINIA S, HASANI A., MIR-SALEHAIAN A, SHOHRABI N, ABBASI L. High prevalence of metallo β-lactamase producing A. baumannii in Teaching Hospital in Tabriz Iran. Jpn J Infect Dis 2011; 64: 69-71.
4. JAZANI NH, ZARTOSHTI M, BABAZADEH H., ALI-DAIEE N. Antibacterial effects of Artemisia dracunculus essential oil on multidrug resistant isolates of Acine-tobacter baumannii. Bacteriology 2011; 1: 31-36.
5. PEREZ F. Challenge of multidrug resistant A. baumannii. Antimicrob Agents Chemother 2007; 51: 3471-3484.
6. PELEG AY, FRANKLIN C, BELL J.M., SPELMAN DW Dissemination of the metallo-β-lactamase gene blaIMP-4 among Gram-negative pathogens in a clinical setting in Australia. Clin Infect Dis 2005; 41: 1549-1556. (Pubitemid 41691591)
7. HERITIER C, POIREL L, LAMBERT T., NORDMANN P. Contribution of acquired carbapenem hydrolyzing oxacillinases to carbapenem resistance in A. baumannii. Antimicrob Agents Chemother 2005; 49: 3198-3202. (Pubitemid 41060561)
8. QUEENAN AM, BUSH K. Carbapenemases the versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440-458.
9. POIREL L, NORDMANN P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-836. (Pubitemid 44151282)
10. EVANS AB, HAMOUD A, AMYES GBS. The Rise of Car-bapenem resistant A. baumannii. Curr Pharm Design 2013; 19: 223-238.
11. CORNAGLIA G, MAZZARIOL A, LAURETTI L., ROSSOLINI RM, FONTANA R. Hospital outbreak of carbapenem resistant Pseudomonas aeruginosa producing VIM-1 a novel transferable metallo-β-lactamase. Clin Infect Dis 2000; 31: 1119-1125. (Pubitemid 32295437)
12. CASTANHEIRA M, TOLEMAN MA, JONES R.N., SCHMIDT FJ, WALSH TR Molecular characterization of β-lacta-mase gene bla GIM-1 encoding a new subclass of metallo-β-lactamase. Antimicrob Agents Chemother 2004; 48: 4654-4661. (Pubitemid 39577668)
13. KONEMAN EW, ALLEN SD, JAND W.M., SCHRECKENBERGER PC, WINN WC Color atlas and textbook of diagnostic microbiology; 5th ed. Williams and Wilkins, 1997.
14. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. Methods for Antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard; 5th ed. Wayne: NCCLS M7-A5, 2000.
15. Chen W.P., Kuo TT A simple and rapid method for the preparation of Gram negative bacterial genomic DNA. Nucleic Acid Research 1993; 21: 2260.
16. SUNG JY, KWON K C, PARK J W, KIM YS, KIM J.M., SHIN KS. Dissemination of IMP-1 and OXA type beta-lacta-mase in carbapenem resistant Acinetobacter bau-mannii. Korean J Lab Med 2008; 28: 16-23.
17. FEIZABADI MM, FATHOLLAHZADEH B, TAHERIKALANI M., RA-SOOLINEJAD M, SADEGHIFARD N, ALIGHOLI M., SOROUSH S, MOHAMADI-YEGANE S. Antimicrobial susceptibility patterns and distribution of bla OXA genes amongm Acinetobacter spp. isolated from patients at Tehran hospitals. Jpn J Infect Dis 2008; 61: 274-278.
18. YANG H.Y., LEE HJ, SUH J.T., LEE KM Outbreaks of imipenem resistant A.baumannii producing OXA-23 β-lactamase in a tertiary care hospital in Korea. Yonsei Med J 2009; 50: 764-770.
19. AL-ARFAJ A., IBRAHIM SS, SOMILY A.M., AL-SALAMAH A. Genetic basis of carbapenem resistance in Acine-tobacter clinical isolates in Saudi Arabia. Afr J Biotechnol 2011; 10: 14186-14196.
20. OZEN N, ERGANI N, NAAS T., OGUNC D, GIILTEKIN D, COLAK, D, NORDMANN P. Outbreak of carbapenem resistant A. baumannii producing the carbapene-mase OXA-58 in Turkey. Antimicrob Agents J 2009; 1: 1-8.
21. DENT LL, MARSHALL DR, PRATAP S, HULETTE RB Multidrug resistant A. baumannii a descriptive study in a city hospital. BMC Infect Dis 2010; 10: 196.
22. LEEPETHACHARAT MD, OBERDORFER MD A. baumannii infection and colonization among pediatric patients at Chiang Mai University Hospital. J Infect Dis Antimicrob Agents 2007; 24: 63-73.
23. SINHA M, SRINIVASA H, MACADEN R. Antibiotic resistance profile and extended spectrum β-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res 2007; 126: 63-67. (Pubitemid 350020550)
24. HERITIER C, POIREL L, LAMBERT T., NORDMANN P. Contribution of acquired carbapenem hydrolyzing oxacillinases to carbapenem resistance in A. baumannii. Antimicrob Agents Chemother 2005; 49: 3198-3202. (Pubitemid 41060561)
25. IKONOMIDIS A, NTOKOU E, MANIATIS A.N., TSAKRIS A., POURNARAS S. Hidden VIM-1 metallo-β-lactamase phenotypes among A. baumannii clinical isolates. J Clin Microbiol 2008; 46: 346-349.
26. CHU YW, CHEUNG TK, NGAN J.Y., KAM KM EDTA susceptibility leading to false detection of metallo-β-lactamase in Pseudomonas aeruginosa by E-test and an imipenem-EDTA disk method. Int J Antimi-crob Agents 2005; 26: 340-341. (Pubitemid 41338665)
27. BERGES L, RODRIGUEZ-VILLALOBOS H, DEPLANO A.N., STRUELENS MJ Prospective evaluation of imipenem - EDTA combined disc and E-test for detection of metallo-β-lactamase-producing Pseudomonas aeruginosa. J Antimicrob Chemother 2007; 59: 812-813. (Pubitemid 47073432)
28. SAMUELSEN O, BUARO L, GISKE C.G., SIMONSEN SG, AASNAS B, SUNDSJORD A. Evaluation of phenotypic tests for the detection of metallo-β-lactamase producing Pseudomonas aeruginosa in a low prevalence country. J Antimicrob Chemother 2008; 61: 827-830. (Pubitemid 351426065)
29. VALENZA G, JOSEPH B, ELIAS J., CLAUS H, OESTERLEIN A. First survey of metallo-β-Lactamases in clinical isolates of Pseudomonas aeruginosa in a German University Hospital. Antimicrob. Agents Chemother 2010; 54: 3493-3497.
30. KAASE M, NORDMANN B, WICHELHAUS T.A., GATERMANN SG, BONNIN RA, POIREL L. NDM-2 carbapenemase in A. baumannii from Egypt. J Antimicrob Chemother 2011; 66: 1260-1262.